Old Web
English
Sign In
Acemap
>
authorDetail
>
Bruno S. Fang
Bruno S. Fang
Medicine
Ibrutinib
Internal medicine
Chronic lymphocytic leukemia
Oncology
4
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
2021
Future Oncology
Jing-Zhou Hou
Kellie Ryan
Senxi Du
Bruno S. Fang
Stanley M. Marks
Ray Page
Eileen Peng
Keith Szymanski
Sharon Winters
Hannah Le
Show All
Source
Cite
Save
Citations (0)
Dose Reductions and Discontinuations with Chronic Lymphocytic Leukemia (CLL) Patients Receiving Ibrutinib in Community and Academic Settings
2020
Blood
Jing-Zhou Hou
Kellie Ryan
Senxi Du
Bruno S. Fang
Stanley M. Marks
Ray Page
Eileen Peng
Keith A Szymanski
Sharon Winters
Hannah Le
Show All
Source
Cite
Save
Citations (1)
Ibrutinib Dose Reductions and Discontinuations Patterns Among Patients with Chronic Lymphocytic Leukemia from a Large Community Medical Oncology Practice
2020
Blood
Senxi Du
Bruno S. Fang
Percy Yeung
Eileen Peng
Marisa Keck
Show All
Source
Cite
Save
Citations (0)
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
2016
American Journal of Clinical Oncology
Matthew P. Deek
Sinae Kim
Inaya Ahmed
Bruno S. Fang
Wei Zou
Jyoti Malhotra
Joseph Aisner
Salma K. Jabbour
Show All
Source
Cite
Save
Citations (7)
1